Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$10,645,406
+$344,460 QoQ
Shares Held
41,916
-0.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,072
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026THOMPSON SIEGEL & WALMSLEY LLC holds $141,170,482 across 11 Drug Manufacturers - General names. JNJ ranks #6 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
274,133 | $35,226,090 | |
| 2 | BIIB |
Biogen Inc.
|
130,512 | $28,198,422 | |
| 3 | ABBV |
AbbVie Inc.
|
72,426 | $18,225,278 | |
| 4 | PFE |
Pfizer Inc
|
589,575 | $14,196,966 | |
| 5 | AMGN |
Amgen Inc
|
34,760 | $12,587,291 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
41,916 | $10,645,406 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
70,332 | $8,885,744 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
121,984 | $7,028,718 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,645,406 | 41,916 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $10,300,946 | 42,141 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $8,921,407 | 43,109 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $8,066,882 | 43,506 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $9,228,849 | 60,418 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $12,954,094 | 78,112 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $15,188,715 | 105,025 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $16,615,849 | 102,529 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $17,208,147 | 117,735 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $18,767,028 | 118,636 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $18,707,859 | 119,356 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $18,763,046 | 120,469 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $19,935,890 | 120,444 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $18,779,180 | 121,156 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $18,985,105 | 107,473 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $17,710,837 | 108,416 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $19,665,977 | 110,788 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $19,056,124 | 107,522 | Shares | Defined | 2022-04-26 | |
| 2021-12-31 | $17,195,272 | 100,516 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $14,277,730 | 88,407 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $13,835,359 | 83,983 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $13,299,695 | 80,923 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $13,091,812 | 83,186 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $12,824,523 | 86,140 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $11,333,934 | 80,594 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $11,170,833 | 85,189 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||